These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18805056)

  • 21. The significance of policy documents in municipal child health promotion.
    Guldbrandsson K; Bäck H; Bremberg S
    Scand J Public Health; 2008 May; 36(3):228-34. PubMed ID: 18519290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of assessment in promoting secondhand smoke policy in a local health jurisdiction.
    Gizzi C; Klementiev A; Britt J; Cruz-Uribe F
    J Public Health Manag Pract; 2009; 15(1):41-6. PubMed ID: 19077593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hazard identification, dose-response and environmental characteristics of stachybotryotoxins and other health-related products from Stachybotrys.
    Lai KM
    Environ Technol; 2006 Mar; 27(3):329-35. PubMed ID: 16548213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shaping child welfare policy via performance measurement.
    Tilbury C
    Child Welfare; 2007; 86(6):115-35. PubMed ID: 18456985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A brief indicator of household energy security: associations with food security, child health, and child development in US infants and toddlers.
    Cook JT; Frank DA; Casey PH; Rose-Jacobs R; Black MM; Chilton M; Ettinger de Cuba S; Appugliese D; Coleman S; Heeren T; Berkowitz C; Cutts DB
    Pediatrics; 2008 Oct; 122(4):e867-75. PubMed ID: 18829785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worldwide regulations for mycotoxins.
    van Egmond HP
    Adv Exp Med Biol; 2002; 504():257-69. PubMed ID: 11922093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a risk-ranking framework to evaluate potential high-threat microorganisms, toxins, and chemicals in food.
    Newsome R; Tran N; Paoli GM; Jaykus LA; Tompkin B; Miliotis M; Ruthman T; Hartnett E; Busta FF; Petersen B; Shank F; McEntire J; Hotchkiss J; Wagner M; Schaffner DW
    J Food Sci; 2009 Mar; 74(2):R39-45. PubMed ID: 19323766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response models: how might we think about linearity and nonlinearity?
    Ricci P
    Hum Exp Toxicol; 2009 Jan; 28(1):29-38. PubMed ID: 19411558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of the strengths and weaknesses of quantitative methods used in health impact assessment.
    O'Connell E; Hurley F
    Public Health; 2009 Apr; 123(4):306-10. PubMed ID: 19324380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixtures in the real world: the importance of plant self-defense toxicants, mycotoxins, and the human diet.
    Mattsson JL
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):125-32. PubMed ID: 17291556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current approaches to making an integral prenosological assessment of the health status of children and adolescents].
    Setko NP
    Gig Sanit; 2009; (4):9-10. PubMed ID: 19799214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The strengths of the ecological risk assessment process: linking science to decision making.
    Barnthouse L
    Integr Environ Assess Manag; 2008 Jul; 4(3):299-305. PubMed ID: 18597567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring mechanisms for quality assurance in primary care systems in transition: test of a new instrument in Slovenia and Uzbekistan.
    Kringos DS; Boerma W; Pellny M
    Qual Prim Care; 2009; 17(3):165-77. PubMed ID: 19622267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk communication and non-linearity.
    Gardner DE
    Hum Exp Toxicol; 2009 Jan; 28(1):27. PubMed ID: 19411557
    [No Abstract]   [Full Text] [Related]  

  • 36. Global policy for improvement of oral health in the 21st century--implications to oral health research of World Health Assembly 2007, World Health Organization.
    Petersen PE
    Community Dent Oral Epidemiol; 2009 Feb; 37(1):1-8. PubMed ID: 19046331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk assessment and cost-effectiveness/utility analysis.
    Busch M; Walderhaug M; Custer B; Allain JP; Reddy R; McDonough B
    Biologicals; 2009 Apr; 37(2):78-87. PubMed ID: 19243972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction--databases and the assessment of complications associated with the treatment of patients with congenital cardiac disease.
    Jacobs JP
    Cardiol Young; 2008 Dec; 18 Suppl 2():1-37. PubMed ID: 19063774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nurses' role in children's environmental health protection.
    Sattler B; Davis del BA
    Pediatr Nurs; 2008; 34(4):329-39. PubMed ID: 18814568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.